{"registerEntryDetail":{"account":{"firstPublicationDate":"2022-02-24T16:10:30.000Z","registerNumber":"R001385"},"activity":{"code":"ACT_ORGANIZATION","de":"Unternehmen","en":"Company"},"activityDescription":"Hexal entwickelt, produziert und vermarktet patentfreie Arzneimittel, sogenannte Generika und Biosimilars an mehreren Standorten in Deutschland und Europa. Unsere Produkte bieten Ärzten, Apothekern und Patienten eine breite Auswahl an Therapieoptionen. Sie stehen für Kompetenz in Forschung und Entwicklung, für guten Service und eine wirtschaftliche Versorgung mit Effizienz. Wir streben an, den Zugang von Patienten zu qualitativ hochwertigen und wirtschaftlichen Arzneimitteln stetig zu verbessern und stehen deshalb im Austausch mit Vertretern aus Wissenschaft, Wirtschaft und Politik.","activityOperationType":"MANDATE_OPERATED","clientOrganizations":[],"clientPersons":[],"codexViolation":false,"disclosureRequirementsExist":true,"donationInformationRequired":false,"donators":[],"employeeCount":{"from":1,"to":10},"fieldsOfInterest":[{"code":"FOI_HEALTH","de":"Gesundheit","en":"Health"},{"code":"FOI_HEALTH|FOI_HEALTH_MEDICINE","de":"Arzneimittel","en":"Medicine"}],"financialExpensesEuro":{"fiscalYearEnd":"12/21","fiscalYearStart":"01/21","from":270001,"to":280000},"id":3878,"legislativeProjects":[],"lobbyistIdentity":{"address":{"city":"Holzkirchen","country":{"code":"DE"},"type":"NATIONAL"},"identity":"ORGANIZATION","legalForm":{"code":"LF_AG","code_de":"Aktiengesellschaft (AG)","code_en":"Stock company (AG)","type":"JURISTIC_PERSON"},"legalRepresentatives":[{"commonFirstName":"Wolfgang","function":"Vorstand","lastName":"Späth","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Peter","function":"Vorstand","lastName":"Stenico","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Matthias","function":"Vorstand","lastName":"Weber","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Dieter","function":"Vorstand","lastName":"Ziebold","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Alexander","function":"Vorstand","lastName":"Salzmann","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Hannes","function":"Vorstand","lastName":"Wörner","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"},{"commonFirstName":"Aarthi","function":"Vorstand","lastName":"Bierl","organizationMemberEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080"}],"membershipEntries":["Pro Generika e.V.","Bundesverband der Arzneimittel-Hersteller e.V."],"name":"HEXAL AG","namedEmployees":[],"organizationEmails":["hexal.kommunikation@hexal.com"],"phoneNumber":"+4980249080","websites":["www.hexal.de"]},"refuseDonationInformation":false,"refuseFinancialExpensesInformation":false,"refusePublicAllowanceInformation":false,"registerEntryMedia":[{"media":{"fileName":"Pro-Generika-Verhaltenskodex-final-6-9-2016.pdf","mimeType":"application/pdf","url":"https://www.lobbyregister.bundestag.de/media/6a/20/11729/Pro-Generika-Verhaltenskodex-final-6-9-2016.pdf"},"type":"CODE_OF_CONDUCT"}]},"registerNumber":"R001385","searchUrl":"https://www.lobbyregister.bundestag.de/suche/R001385/3878","source":"Deutscher Bundestag, Lobbyregister für die Interessenvertretung gegenüber dem Deutschen Bundestag und der Bundesregierung","sourceUrl":"https://www.lobbyregister.bundestag.de"}